LQDA earnings date and last-quarter result: last quarter beat, P/E 364.03. Updated 2026-07-23.
Liquidia (LQDA) Research Hub
Liquidia (LQDA) trades on NASDAQ, US in the Healthcare (Medical - Pharmaceuticals) sector. As of 2026-10-26, shares last closed at 43.74 USD (+2.56%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 364.03, market cap 7.63B. This hub links to the full technical, earnings and options research available for LQDA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Pharmaceuticals) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 43.74 USD (+2.56%) |
| 52-week range | 22.31 USD – 93.61 USD |
| Trend regime | Range |
| 14-day RSI | 90.3 (Overbought) |
| Trailing P/E | 364.03 |
| Market cap | 7.63B |
| Dividend yield | 0.00% |
Available research for LQDA
Covered Call on LQDA: how it works, illustrative setup around the real 43.74 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LQDA: how it works, illustrative setup around the real 43.74 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LQDA: how it works, illustrative setup around the real 43.74 USD price, max profit/loss, breakeven and when to use it. Educational.
LQDA technical analysis: range, last 43.74 USD, RSI 90.3, 52w range 22.31 USD–93.61 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is LQDA in?
Liquidia (LQDA) is classified under Healthcare (Medical - Pharmaceuticals), listed on NASDAQ, US.
Is LQDA in an uptrend or downtrend?
As of 2026-10-26, LQDA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LQDA's trailing P/E ratio?
LQDA's trailing P/E is 364.03, with a market cap of 7.63B. See the earnings research page for full valuation detail.